A randomized study of decitabine versus conventional care for maintenance therapy in patients with acute myeloid leukemia in complete remission

Y. Boumber*, H. Kantarjian, J. Jorgensen, S. Wen, S. FaDerl, R. Castoro, J. Autry, G. Garcia-Manero, G. Borthakur, E. Jabbour, Z. Estrov, J. Cortes, J. P. Issa, F. Ravandi

*Corresponding author for this work

Research output: Contribution to journalLetter

36 Scopus citations
Original languageEnglish (US)
Pages (from-to)2428-2431
Number of pages4
JournalLeukemia
Volume26
Issue number11
DOIs
StatePublished - Nov 2012

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Boumber, Y., Kantarjian, H., Jorgensen, J., Wen, S., FaDerl, S., Castoro, R., Autry, J., Garcia-Manero, G., Borthakur, G., Jabbour, E., Estrov, Z., Cortes, J., Issa, J. P., & Ravandi, F. (2012). A randomized study of decitabine versus conventional care for maintenance therapy in patients with acute myeloid leukemia in complete remission. Leukemia, 26(11), 2428-2431. https://doi.org/10.1038/leu.2012.153